Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis
Abstract Background Cisplatin resistance is among the main reasons for the poor prognosis of ovarian cancer (OC) patients. Until now, effective biomarkers for predicting cisplatin resistance in OC and specific drugs for reversing this resistance are lacking. This study identified the critical gene a...
Main Authors: | Qingsong Zeng, Cunjian Yi, Jinzhi Lu, Xiaowen Wang, Keming Chen, Li Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5637 |
Similar Items
-
Identification of potential hub genes and therapeutic drugs in ovarian cancer via bioinformatics analysis
by: Xinyue Zhou, et al.
Published: (2023-12-01) -
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
by: Dan Yang, et al.
Published: (2020-01-01) -
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis
by: Yaowei Li, et al.
Published: (2019-11-01) -
Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics
by: Varun Chandra Alur, et al.
Published: (2019-04-01) -
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer
by: Li Li, et al.
Published: (2017-04-01)